Abstract:Background Aspirin, the most widely used nonsteroidal anti-inflammatory drug, damages the gastrointestinal tract. Interactions between Aspirin and gut microbiota have been reported. However, the impact of microbiome altered by Aspirin in intestinal homeostasis remains unclear. We aim to determine the roles of Aspirin-altered microbiota in intestinal injury. Methods Healthy volunteers (N=23) were administrated with Aspirin (100mg/day) for 30 days (IDDF2022-ABS-0097 Figure 1A. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Shotgun metagenomics analysis on paired fecal samples before (BA) and after Aspirin (AA) administration was performed. Mice were treated with Asprin and fecal samples were subjected to 16s-sequencing and metabolomics by gas chromatography coupled to time-of-flight mass spectrometry. Fecal Microbiome Transplantation (FMT) for mice were conducted and intestinal injury was assessed by Chiu’s grades. Cell proliferation and apoptosis were determined through Ki67 and TUNEL staining. Intestinal permeability was evaluated by FITC-labeled dextran. Results Partial least squares discriminant analysis and linear discriminant analysis showed differences in the gut microbiome profiles (IDDF2022-ABS-0097 Figure 1B-C. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). The abundance of Parabacteroide goldsteinii (P. goldsteinii) were found to be decreased in AA group (IDDF2022-ABS-0097 Figure 1 D-E. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Similar results were also found by 16s-sequencing in Aspirin-induced mice models (IDDF2022-ABS-0097 Figure 1F-G. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Scores of intestinal injury were negatively correlated with the abundance of P. goldsteinii (IDDF2022-ABS-0097 Figure 1H, J-M. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Intestinal concentrations of bile acids in mice were correlated with the abundance of P. goldsteinii (IDDF2022-ABS-0097 Figure 1I. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). More interestingly, FMT (IDDF2022-ABS-0097 Figure 1N. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis) from donating mice treated with Aspirin to NC mice induced intestinal injury, whereas FMT of NC mice to Aspirin-treated mice, helped intestinal repairment and decreased the intestinal injury score (IDDF2022-ABS-0097 Figure 1O-P. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Further, gavage of P. goldsteinii rescued Aspirin-induced intestinal injury (IDDF2022-ABS-0097 Figure 1Q-R. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis), promoted the proliferation of cells in crypts (IDDF2022-ABS-0097 Figure 1S-T. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis), decreased apoptosis (IDDF2022-ABS-0097 Figure 1U-V. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis) and preserved intestinal permeability (IDDF2022-ABS-0097 Figure 1W. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). These suggest that the Aspirin-suppressed microbiome, such as P. goldsteinii may be involved in the maintenance of intestinal homeostasis, which was disturbed by Aspirin treatment. Conclusions Aspirin leads to dysbiosis of gut microbiota, which impairs the homeostasis of the intestinal mucosa (IDDF2022-ABS-0097 Figure 1X. Aspirin impairs intestinal homeostasis through gut microbiota metabolites axis). Supplement of probiotics P. goldsteinii may be a promising strategy to prevent Aspirin-induced GI damage.

A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage

IDDF2022-ABS-0097 Aspirin Impairs Intestinal Homeostasis Through Gut Microbiota-Bile-acids Axis

IDDF2019-ABS-0188 Gut Microbiota Modulates the Chemopreventive Efficacy of Aspirin on Colorectal Cancer Through Impact on Aspirin Bioavailability

<i>Akkermansia muciniphila</i> Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism

Bifidobacterium Longum R0175 Protects Mice Against APAP-induced Liver Injury by Modulating the Nrf2 Pathway.

Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury

Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE-/- mice

Protective Effect and Mechanism of Aspirin Eugenol Ester on Lipopolysaccharide-Induced Intestinal Barrier Injury

Fecal 16S rRNA Gene Sequencing Analysis of Changes in the Gut Microbiota of Rats with Low-Dose Aspirin-Related Intestinal Injury

Naturally Occurring TPE-CA Maintains Gut Microbiota and Bile Acids Homeostasis via FXR Signaling Modulation of the Liver-Gut Axis

Bile acids as modulators of gut microbiota composition and function

Aspirin Reduces Colorectal Tumor Development in Mice and Gut Microbes Reduce Its Bioavailability and Chemopreventive Effects.

Bile acid supplementation improves murine pancreatitis in association with the gut microbiota

Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis

P054 Modulation of the Gut Microbiota-Farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice

The effect of an acute aspirin challenge on intestinal permeability in healthy adults with and without prophylactic probiotic consumption: a double-blind, placebo-controlled, randomized trial

Akkermansia muciniphila Ameliorates Acetaminophen-Induced Liver Injury by Regulating Gut Microbial Composition and Metabolism

Bile Acid–Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside

PPARα-UGT Axis Activation Represses Intestinal FXR-FGF15 Feedback Signalling and Exacerbates Experimental Colitis

The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin

Hepatic cytochrome P450 8B1 and cholic acid potentiate intestinal epithelial injury in colitis by suppressing intestinal stem cell renewal